AstraZeneca Nexium Data Shows 47% Of Scripts Are First-Time PPI Users

Nexium sales data from the U.K. and Germany shows that 47% of prescriptions are for patients new to proton pump inhibitors, AstraZeneca CEO Tom McKillop, PhD, reported at the company's year-end earnings conference in London Feb. 8.